What impresses me is the clinical trial quality and the fairly low cost.
Only c.$1M AUD to complete Phase 2a when typical Phase 2 trials are 10x the cost to run.
We will have a comprehensive understanding of the mode of action and Dengue efficacy late 2022. Sit and wait investment.
Ann: ISLA-101 Phase 2a clinical trial update, page-8
Add ILA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.366M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13058 | 6.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 14085 | 1 |
View Market Depth
| Last trade - 16.12pm 19/07/2024 (20 minute delay) ? |
| ILA (ASX) Chart |
Day chart unavailable